WKN: | A0JEGY |
ISIN: | AU000000CUV3 |
Land: | Australien |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Clinuvel Pharmaceuticals-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 16. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2014 | 0,6400 | 2,7300 | 326,56% |
2 | 2016 | 1,8000 | 4,9800 | 176,67% |
3 | 2006 | 2,1100 | 4,5000 | 113,27% |
4 | 2018 | 5,3900 | 10,9000 | 102,23% |
5 | 2019 | 10,9000 | 17,9000 | 64,22% |
6 | 2009 | 1,2000 | 1,8700 | 55,83% |
7 | 2012 | 1,1800 | 1,5800 | 33,90% |
8 | 2021 | 13,9300 | 18,3000 | 31,37% |
9 | 2017 | 4,9800 | 5,3900 | 8,23% |
10 | 2025 | 7,1500 | 6,8000 | -4,90% |
11 | 2010 | 1,8700 | 1,6700 | -10,70% |
12 | 2020 | 17,9000 | 13,9300 | -22,18% |
13 | 2022 | 18,3000 | 13,5300 | -26,07% |
14 | 2023 | 13,5300 | 9,9200 | -26,68% |
15 | 2024 | 9,9200 | 7,1500 | -27,92% |
16 | 2011 | 1,6700 | 1,1800 | -29,34% |
17 | 2015 | 2,7300 | 1,8000 | -34,07% |
18 | 2008 | 2,1000 | 1,2000 | -42,86% |
19 | 2007 | 4,5000 | 2,1000 | -53,33% |
20 | 2005 | 5,1700 | 2,1100 | -59,19% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 1,5800 | 0,6400 | -59,49% |
2 | 2005 | 5,1700 | 2,1100 | -59,19% |
3 | 2007 | 4,5000 | 2,1000 | -53,33% |
4 | 2008 | 2,1000 | 1,2000 | -42,86% |
5 | 2015 | 2,7300 | 1,8000 | -34,07% |
6 | 2011 | 1,6700 | 1,1800 | -29,34% |
7 | 2024 | 9,9200 | 7,1500 | -27,92% |
8 | 2023 | 13,5300 | 9,9200 | -26,68% |
9 | 2022 | 18,3000 | 13,5300 | -26,07% |
10 | 2020 | 17,9000 | 13,9300 | -22,18% |
11 | 2010 | 1,8700 | 1,6700 | -10,70% |
12 | 2025 | 7,1500 | 6,8000 | -4,90% |
13 | 2017 | 4,9800 | 5,3900 | 8,23% |
14 | 2021 | 13,9300 | 18,3000 | 31,37% |
15 | 2012 | 1,1800 | 1,5800 | 33,90% |
16 | 2009 | 1,2000 | 1,8700 | 55,83% |
17 | 2019 | 10,9000 | 17,9000 | 64,22% |
18 | 2018 | 5,3900 | 10,9000 | 102,23% |
19 | 2006 | 2,1100 | 4,5000 | 113,27% |
20 | 2016 | 1,8000 | 4,9800 | 176,67% |